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Purpose/Objective: Although helical tomotherapy (HT) is not capable 
of producing noncoplanar beams, its potential to delivery effective 
stereotactic body radiation therapy SBRT treatments has been widely 
demonstrated. Due to the high fraction dose required, HT-based SBRT 
is commonly planned with the narrowest field width (1 cm) and small 
pitch values (approximately 0.1), leading to a significant increase of 
the beam-on time (BOT). HT unit features a flattening filter (FF) free 
6MV photon beam providing an high dose-rate (>800 MU/min) and an 
unflattened dose profile in the lateral direction. The ratios of the off-
axis dose at 5 cm and 10 cm and the maximum dose are 88% and 71%, 
respectively. Thus, the increased dose rate does not directly 
translates into shorter BOTs, since the treatment time results affected 
also by the window of the dose profile involved in the fluence 
modulation. The aim of this work was to investigate the variation of 
the BOT required to deliver a SBRT fraction to a single lung lesion as a 
function of the distance of the PTV from the isocenter (IC) of the 
treatment unit taking also into account the PTV dimensions, assuming 
the volume as an ideal sphere.  
Materials and Methods: 6 patients who previously received SBRT to a 
single-lung lesion were retrospectively replanned repositioning the 
PTV according to the IC of the treatment unit. Plans were redesigned 
keeping the dose constraints unchanged during the optimization and 
DVHs comparison was performed to assess the identity between plans. 
The module of the vector ρ with origin in the IC and lying in the axial 
plane measured the off-axis PTV distance. To account for fraction 
dose and ρ variability, the normalized coefficient ΔBOTnorm was 
introduced to quantify the BOT reduction: 
 
  
where ΔBOT is the BOT difference between the two plans. 
Differences in fraction doses, PTV off-axis positions and diameters (∅) 
are reported in Table 1. 
Results: Deviations between DVHs were all within the 1% in terms of 
both dose and volume difference. A mean reduction in gantry period 
of 3.8s (range 2s – 5s) was observed yielding a ΔBOT mean value of 
116.7s (range 73.8s – 143.1s).  
The ΔBOTnorm mean value was 1.78s/Gy·cm (range 1.4 s/Gy·cm – 2.2 
s/Gy·cm). ΔBOTnorm showed to vary linearly (R2 = 0.999) with ∅ as 
plotted in Figure 1. Higher ΔBOTnorm values were observed for 
sinograms with low fluence contribution by the inner leaves. The 
overall results for each patient are reported in Table 1. 
 
Table 1. 
  
Figure 1. 
  
Conclusions: BOT value required for HT-based SBRT treatments 
resulted to be affected by the PTV distance from IC. The increase of 
the mean fluence intensity yielded by moving the PTV towards the IC 
allows the increase of the gantry speed, thus reducing the overall 
BOT. BOT reduction increased linearly with PTV volume. For the 6 
patients involved, the study showed the potential to decrease the BOT 
up to a factor of 17% which may be considered noticeable with regard 
to the typical range (10 min to 25 min) involved for such treatments. 
Further studies will be focused on the ΔBOTnorm variation as a 
function of the fluence modulation. 
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Purpose/Objective: In stereotactic body radiotherapy (SBRT), the 
positional stability of the target is important to reduce the risk of a 
geographic miss. It has been suggested that long treatment times may 
be associated with greater changes in intrafraction tumor position, 
which if uncorrected could adversely affect target coverage. High 
dose rate flattening filter free (FFF) beams have recently become 
clinically available and these enable short delivery times, especially 
when combined with volumetric modulated arc therapy. The purpose 
of this study was to evaluate intrafraction target stability position 
during fast, frameless FFF lung SBRT and to report how long this 
treatment takes to deliver. 
Materials and Methods: 140 lung SBRT fractions in 32 patients with 
early stage lung cancer or lung metastasis delivered with FFF 
RapidArc® on a TrueBeam™ accelerator at a maximum dose rate of 
2400 MU/minute were reviewed. Dose-fractionation was risk-adapted, 
taking into account tumor size and critical organs. Fractions without 
post-treatment CBCT, performed without high dose rate delivery and 
with session interruption due to coughing or match uncertainty, were 
excluded from this analysis. After initial positioning using lasers, a 
pre-treatment kilovoltage free-breathing (3D) cone-beam computed 
tomography scan (CBCT) was performed with on-line automatic ± 
manual co-registration of the time-averaged target with the average-
intensity projection of the planning 4DCT. After the couch shift, the 
two treatment arcs were delivered, followed by a post-treatment 
CBCT. The translational corrections for the post-treatment CBCT 
(taking into account any intermediate CBCT scans) represented the 
intrafraction change in position of the time-averaged target (Δ). For 
89% of the fractions, the translational data resolution was 0.1mm. A 
3D vector was calculated for each fraction and time metrics were 
calculated. The relation between Δ and treatment time was 
investigated. 
Results: Mean Δ was -0.7 mm (SD=1.4), -0.7 mm (SD=1.3), and +0.2 
mm (SD=1.2) in vertical, longitudinal and lateral directions, 
respectively, with a mean 3D vector of 2.1 mm (SD=1.2). 52% of 3D 
vectors were <2 mm and 96% <5 mm. Mean time for arc delivery was 
4.4 min (SD=3.4) with mean beam-on 1.9 min (SD=0.4). Mean time 
between first and last CBCT was 11.6 min (6.8- 40.4 min, SD=4.0 min). 
Mean 3D vector for upper (n=16) and mid- or lower third lesions (n=18) 
was 2.0 and 2.2 mm, respectively (p=0.20). No correlation was found 
between the 3D vector and time. The addition of a single 
intermediate CBCT added approximately 7 min to the mean fraction 
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time. 
Conclusions: SD for Δ was <1.5 mm in all directions, suggesting 
relatively good stability in the time-averaged position of these mobile 
targets. Delivery times were short and no correlation was observed 
between Δ and time. The results support frameless, free-breathing, 
lung SBRT performed with FFF RapidArc.  
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Purpose/Objective: Stereotactic irradiation of pancreatic cancers is 
hampered by respiratory movements of the tumor. An ITV that 
encloses the peak-to-peak breathing amplitude yields large PTVs and, 
therefore, may potentially harm nearby organs at risk. Gated delivery 
enables ITV reduction. However, this will increase treatment time as 
the radiation beam periodically is switched on and off. The aim of this 
work is to assess pancreatic tumor motion in order to find a patient 
specific optimal tradeoff between duty cycle and ITV. 
Materials and Methods: 12 pancreatic cancer patients were imaged 
for a minute using cine-MRI on a 1.5T scanner. Sagittal and coronal 
scans, located through the center of the tumor, were acquired using a 
mixed T1/T2 weighted sequence (bSSFP) at a rate of two frames per 
second and a slice thickness of 7mm (fig 1A). Tumor tracking was 
performed with a Minimum Output Sum of Squared Error (MOSSE) 
adaptive correlation filter, which enables real-time tracking of a 
moving object. 
Results: The greatest pancreatic tumor motion was found in cranio-
caudal direction (mean 24mm, SD 13mm, range 10-49mm). The end-
exhale position (EEP) was consistently reproduced (1SD=1.1mm, over 
all patients) whereas the end-inhale position (EIP) was less consistent 
(1SD=2.3mm, over all patients) (fig 1B). Further analysis also revealed 
that the tumors spend more time close to the EEP than to the EIP 
(average EIP/EEP ratio = 0.70, range 0.62-0.85). Both findings support 
the preference of gating around the EEP. At free breathing conditions, 
the entire breathing amplitude needs to be added to the ‘static’ CTV 
at EEP to build the ITV. However, this margin decreases dramatically - 
to a quarter of the amplitude (range 13%-40%) – when a gating duty 
cycle of 50% is used (beam on time = beam off time) (fig 1C). 
 
  
Conclusions: Gated delivery for stereotactic radiotherapy of 
pancreatic cancer is best performed around the end-exhale position. 
Considerable CTV-to-ITV margin reduction can be established at 
moderate gating windows, yielding acceptable treatment efficiency. A 
semi-automated method was developed to optimize gating window for 
individual patients. 
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Purpose/Objective: Cranial stereotactic radiosurgery treatment could 
today be delivering by different arctherapy techniques. In order to 
select the best one according to the number and the position of the 
lesions we compare in this study dynamic conformal arc, coplanar 
VMAT and noncoplanar VMAT. 
Materials and Methods: Patients with single lesion (n=5), multiple 
lesions (n=5) and single lesion close to organs at risk (n=4) and 
previously treated with dynamic conformal arc (DCA) were selected 
for this analysis. For each patient, two additional plans were 
generated using 2 coplanar arc VMAT (RAC) and noncoplanar arc VMAT 
(RANC). For single lesions, the ballistic for RANC is the same as for DCA 
(3-4 arcs per lesion). In multiple lesions case, only 4 noncoplanar arcs 
were used with a single isocenter compare with a multiple isocenter 
treatment for DCA. All plans were evaluated in regard to conformity 
and homogeneity indexes for PTV (CI= (PTV covered by prescription 
isodose)²/VPTV*VPresciption isodose and I=(Dmax-Dmin)/Dmean ), the healthy brain 
tissue dose (goal V10Gy < 12,5cc) , the dose to organs at risk and the 
number of monitor units (MU). 
Results: Concerning single lesion, the HI and the CI were better RANC 
but DCA improved healthy brain protection and treatment delivery 
time even if global room occupation is higher. For multiple lesions, 
VMAT techniques provided similar homogeneity and conformity 
degrees. The healthy brain was as well protected with DCA as with 
RANC. If we look the MU numbers, RAC <RANC < DCA. For single lesion 
close to OAR, the HI was similar for VMAT techniques but RAC 
improved the protection of healthy brain and organs at risk. On the 
other hand, the delivery treatment time is shorter with DCA even if 
overall time is lower with RAC  
 
 
Conclusions: For a single lesion, DCA provide better plan considering 
low doses to healthy brain even if quality indexes are better for the 
others techniques. For multiple lesions, RANC seems to be the best 
solution because it is able to deliver a good conformity and 
homogeneity plan while sparing healthy brain tissue. For a single 
lesion close to organs at risk, results are better with RAC at the cost of 
an increase of MU but a lower treatment time compare with RANC.  
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Purpose/Objective: To investigate the impact of bone marrow (BM) 
radiation dose on standardized uptake value (SUV) changes of 
18Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) 
taken pre and after chemo-radiotherapy in patients with cervical 
cancer, and to study the correlation between uptake values and 
acute/late hematological toxicity, respectively. 
